@article{95a51fac81f44be1a3299b799a84cb9b,
title = "Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop",
abstract = "In November 2015, the CALYM Carnot Institute held a 2-d workshop to discuss the current and future development of immunomodulatory antibodies for the treatment of lymphoma. Highlights from the workshop are presented in this article.",
keywords = "Immunomodulation, immunotherapy, lymphoma, programmed cell death 1 ligand 1, programmed cell death 1 receptor",
author = "Roch Houot and Philippe Gaulard and Robert Schreiber and Ira Mellman and Olivier Lambotte and Coulie, {Pierre G.} and Thierry Fest and Alan Korman and Ronald Levy and Margaret Shipp and Karin Tarte and Holbrook Kohrt and Aur{\'e}lien Marabelle and Stephen Ansell and Herv{\'e} Watier and {van Elsas}, Andrea and Arun Balakumaran and {Arce Vargas}, Frederick and Quezada, {Sergio A.} and Gilles Salles and Daniel Olive",
note = "Publisher Copyright: {\textcopyright} 2016 Taylor & Francis Group, LLC.",
year = "2016",
month = jul,
day = "2",
doi = "10.1080/2162402X.2016.1186323",
language = "English",
volume = "5",
journal = "OncoImmunology",
issn = "2162-4011",
number = "7",
}